BTIG Reiterates Buy Rating on Enliven Therapeutics (ELVN)

Go back to BTIG Reiterates Buy Rating on Enliven Therapeutics (ELVN)
(NASDAQ: ELVN) Delayed: 58.82 +0.76 (1.31%)
Previous Close $58.06    52 Week High
Open $57.67    52 Week Low
Day High $58.90    P/E N/A 
Day Low $56.69    EPS
Volume 350,292